Summary & Overview
Myeloproliferative Disorders or Poorly Differentiated Neoplasms: Inpatient Reimbursement Overview
DRG 829 covers inpatient stays for patients with myeloproliferative disorders or poorly differentiated neoplasms undergoing other procedures with a Complication or Comorbidity or Major Complication or Comorbidity, impacting case complexity. This Diagnosis-Related Group matters for inpatient reimbursement because diagnosis severity, documented complications or comorbidities, and coded procedures affect Centers for Medicare & Medicaid Services payment and resource allocation.
DRG 829 Overview
DRG 829 includes inpatient stays for patients with myeloproliferative disorders or poorly differentiated neoplasms who undergo other procedures and have either a Complication or Comorbidity or a Major Complication or Comorbidity. Clinical scope covers hematologic malignancies and aggressive neoplasms requiring procedures such as bone marrow interventions, central venous access, or other operative/supportive procedures. This Diagnosis-Related Group matters for Centers for Medicare & Medicaid Services payment because the presence of Complication or Comorbidity or Major Complication or Comorbidity and performed procedures influences the relative weight and reimbursement for the hospitalization. Accurate coding of diagnosis severity and procedures is essential to align payment with resource use.